Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma

Biomedicine and Pharmacotherapy

Volumn 64, Issue 6, 2010, Pages 424-429

  Jiang, Ying ^a   Hong Zhang, Shu ^a   Qing Han, Guo ^a   Yong Qin, Cheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

EIF4E; Oxidative stress; PDCD4

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; HYDROGEN PEROXIDE; INITIATION FACTOR 4E; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGRAMMED CELL DEATH FACTOR 4; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANTHRACENES; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; OXIDATIVE STRESS; PHOSPHORYLATION; RNA-BINDING PROTEINS;

EID: 77954309334     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.01.015     Document Type: Article

References (30)

1. Cmarik J.L., Min H.Z., Hegamyer G., Zhan S., Kul-Martin M., Yoshinaga H., et al. Differentially expressed protein Pdcd4 inhibits tumor promoter (TPA)-induced neoplastic transformation. Proc Natl Acad Sci U S A 1999, 96u:14037-14042.
2. Jansen A.P., Camalier C.E., Colburn N.H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005, 65:6034-6041.
3. Bitomsky N., Böhml M., Klempnauer K.H. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosp4horylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 2004, 23:7484-7493.
4. Yang H.S., Matthews C.P., Clair T., Wang Q., Baker A.R. Tumorigenesis suppressor pdcd4 down-regulates Mitogen-Activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 2006, 26:1297-1306.
5. Yang H.S., Jansen A.P., Komar A.A., Zheng X.J., Merrick W.C., Costes S., et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003, 23:26-37.
6. LeBlanc N.L., Santhanam A.N., Baker A.R., Wlodawer A., Colburn N.H. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 2007, 27:147-156.
7. Yang H.S., Cho M.H., Zakowicz H., Hegamyer G., Sonenberg N., Colburn1 N.H. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 2004, 24:3894-3906.
8. Jansen A.P., Camalier C.E., Stark C., Colburn N.H. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 2004, 3:103-110.
9. Lamphear B.J., Kirchweger R., Skern T., Rhoads R.E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases, implications for cap-dependent and cap-independent translational initiation. J Biol Chem 1995, 270:21975-21983.
10. Sonenberg N., Gingras A.C. The mRNA 5' cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 1998, 10:268-275.
11. Shenberger J.S., Adams M.H., Zimmer S.G. Oxidant-induced hypertrophy of A549 cells is accompanied by alterations in eukaryotic translation initiation factor 4E and 4E-binding protein-1. Am J Respir Cell Mol Biol 2002, 27:250-256.
12. Rao G.N. Oxidant stress stimulates phosphorylation of eIF4E without an effect on global protein synthesis in smooth muscle cells. J Biol Chem 2000, 275:16993-16999.
13. Knauf U., Tschopp C., Gram H. Negative regulation of protein translation by Mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol 2001, 21:5500-5511.
14. Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H., Sherman N.E. Pagano1M. S6K1- and bTRCP-mediated degradation of Pdcd4 promotes protein translation and cell growth. Science 2006, 314:467-471.
15. Palamarchuk A., Efanov A., Maximov V., Aqeila R.I. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 2005, 65:11282-11286.
16. Hsieh Y.H., Su I.J., Wang H.C., Chang W.W., Lei H.Y., Lai M.D., et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004, 25:2023-2032.
17. Choi1 J., James-Ou J.-H. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006, 290:G847-G851.
18. Waris G., Turkson J., Hassanein T., Siddiqui A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol 2005, 79:1569-1580.
19. Mattie M.D., Freedman J.H. Copper-inducible transcription: regulation by metal- and oxidative stress responsive pathways. Am J Physiol Cell Physiol 2004, 286:C293-301.
20. Petrak J., Myslivcova D., Man P., Cmejla R., Cmejlova J., Vyoral D. Proteomic analysis of iron overload in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1059-G1066.
21. Tsukamoto H.L.U.S.C. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001, 15:1335-1349.
22. Adams L.A., Angulo P., Lindor K.D. Nonalcoholic fatty liver disease. J Ayub Med Coll Abbottabad 2005, 172:900-905.
23. Zhou Z.X., Wang L.P., Song Z.Y., Lambert J.C., McClain C.J., Kang Y.J. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-α production. Am J Pathol 2003, 163:1137-1146.
24. Mantovani G., Madeddu C., Macciò A., Gramignano G., Lusso M.R., Massa E., et al. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 2004, 13:1651-1659.
25. Mori K., Shibanuma M., Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004, 64:7464-7472.
26. Feig D.I., Reid T.M., Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res 1994, 54:4s. 1890.
27. Okada F., Kobayashi M., Tanaka H., Kobayashi T. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol 2006, 169:294-302.
28. Wang X.M., Flynn A., Waskiewicz A.J., Webb B-LJ, Vries R.G., Baines I.A., et al. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 1998, 273:9373-9377.
29. Cherla R.P, Lee S.Y., Mees P.L., Tesh V.L. Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line. J Leukoc Biol 2006, 79:397-407.
30. Morley S.J., McKendrick L. Involvement of stress-activated protein kinase and p38/RK Mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells. J Biol Chem 1997, 272:17887-17893.